Related Experiment Video
Updated: Dec 29, 2025
A Tactile Automated Passive-Finger Stimulator TAPS
Published on: June 3, 2009
The Power Derivative Principle, and Its Application to How and When to Perform a One-Shot Unblinded Reassessment
Elodie Blondiaux1, Eric Derobert2
1Statistical Department, Effi-Stat, 22, rue du Pont-Neuf, Paris, 75001, France. elodie.blondiaux@effi-stat.com.
Background:
In adaptive two-group clinical trials, a current method is to perform a one-shot unblinded sample size reassessment. Whereas the interim unblinded look of the data is adjusted for inference by using the weighted Cui-Hung-Wang statistics, some questions remain: how and when to reassess the sample size?
Methods:
We define the Power Derivative Principle as follows: a sample size is optimal when the derivative of the power with respect to the sample size has reached some implicit value. Applied to two-group clinical trials, this Power Derivative Principle determines a new one-shot unblinded sample size reassessment rule (including the determination of futility bounds). A full Power Derivative Strategy induces furthermore an optimal information fraction for the interim analysis. The Power Derivative Strategy is then compared to adaptive design methods proposed in the literature and to group sequential strategies. For this comparison, we used, on the one hand, the very common information fraction f = 0.5 and, on the other hand, the information fraction found as being optimal with the Power Derivative Principle.
Results:
The optimal information fraction depends only on α-and β-risks. For usual values of these risks, the optimal information fraction value is very close to 0.9. Moreover, with this unexpected optimal value, reassessment methods become roughly comparable (it is definitely not the case when f=0.5).
Conclusions:
Our results suggest that a sample size reassessment is more beneficial when considered close to the planned end of a trial, allowing a study with borderline interim results to be saved.
More Related Videos
Related Concept Videos
01:24Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:09Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
01:10P-value
P-value stands for the probability value. P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
01:19Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...